Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gautier, Violette ^a   Cayrol, Corinne ^a   Farache, Dorian ^a   Roga, Stéphane ^a   Monsarrat, Bernard ^a   Burlet Schiltz, Odile ^a   Gonzalez De Peredo, Anne ^a   Girard, Jean Philippe ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; IL33 PROTEIN, HUMAN; INTERLEUKIN 33; RNA;

CELL NUCLEUS; EXTRACELLULAR SPACE; GENE KNOCKDOWN; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

CELL NUCLEUS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SPACE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-33; RNA; TANDEM MASS SPECTROMETRY;

EID: 84989844280     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34255     Document Type: Article

References (50)

1. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
2. Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104, 282-287 (2007).
3. Cayrol, C. & Girard, J. P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 31C, 31-37, doi:10.1016/j.coi.2014.09.004 (2014).
4. Molofsky, A. B., Savage, A. K. & Locksley, R. M. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity 42, 1005-1019, doi:10.1016/j.immuni.2015.06.006 (2015).
5. Liew, F. Y., Pitman, N. I. & McInnes, I. B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10, 103-110 (2010).
6. Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+ )Sca-1(+ ) lymphoid cells. Nature 463, 540-544 (2010).
7. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
8. Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107, 11489-11494 (2010).
9. Mjosberg, J. M. et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12, 1055-1062, doi:10.1038/ni.2104 (2011).
10. Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568, doi:10.1038/nature13577 (2014).
11. Kolodin, D. et al. Antigen-and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metab 21, 543-557, doi:10.1016/j.cmet.2015.03.005 (2015).
12. Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol 16, 276-285, doi:10.1038/ni.3085 (2015).
13. Molofsky, A. B. et al. Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity 43, 161-174, doi:10.1016/j.immuni.2015.05.019 (2015).
14. Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293-301, doi:10.1038/nature14189 (2015).
15. Moffatt, M. F. et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363, 1211-1221, doi:10.1056/NEJMoa0906312 (2010).
16. Byers, D. E. et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 123, 3967-3982, doi:10.1172/JCI65570 (2013).
17. Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242-246, doi:10.1038/nature14115 (2015).
18. Lee, M. W. et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74-87, doi:10.1016/j.cell.2014.12.011 (2015).
19. Kearley, J. et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 42, 566-579, doi:10.1016/j.immuni.2015.02.011 (2015).
20. Mager, L. F. et al. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest 125, 2579-2591, doi:10.1172/JCI77347 (2015).
21. Moussion, C., Ortega, N. & Girard, J. P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 3, e3331 (2008).
22. Kuchler, A. M. et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 173, 1229-1242 (2008).
23. Pichery, M. et al. Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain. J Immunol 188, 3488-3495, doi:10.4049/jimmunol.1101977 (2012).
24. Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J. & Kipnis, J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85, 703-709, doi:10.1016/j.neuron.2015.01.013 (2015).
25. Hardman, C. S., Panova, V. & McKenzie, A. N. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 43, 488-498, doi:10.1002/eji.201242863 (2013).
26. Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106, 9021-9026 (2009).
27. Luthi, A. U. et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31, 84-98 (2009).
28. Bessa, J. et al. Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J Autoimmun, doi:10.1016/j. jaut.2014.02.012 (2014).
29. Lefrancais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109, 1673-1678, doi:10.1073/pnas.1115884109 (2012).
30. Lefrancais, E. et al. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci USA 111, 15502-15507, doi:10.1073/pnas.1410700111 (2014).
31. Cohen, E. S. et al. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun 6, 8327, doi:10.1038/ncomms9327 (2015).
32. Roussel, L., Erard, M., Cayrol, C. & Girard, J. P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9, 1006-1012 (2008).
33. Ali, S. et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187, 1609-1616, doi:10.4049/jimmunol.1003080 (2011).
34. Shao, D. et al. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochem Biophys Res Commun 451, 8-14, doi:10.1016/j.bbrc.2014.06.111 (2014).
35. Ni, Y. et al. The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. Int J Mol Sci 16, 27956-27966, doi:10.3390/ijms161126063 (2015).
36. Shan, J. et al. Interferon gamma-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines. PLoS One 11, e0151701, doi:10.1371/journal.pone.0151701 (2016).
37. Demyanets, S. et al. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 31, 2080-2089, doi:10.1161/ATVBAHA.111.231431 (2011).
38. Pollheimer, J. et al. Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler Thromb Vasc Biol 33, e47-e55, doi:10.1161/ATVBAHA.112.253427 (2013).
39. Choi, Y. S. et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 114, 3117-3126 (2009).
40. Gautier, V. et al. Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol Cell Proteomics 11, 527-539, doi:10.1074/mcp. M111.015230 (2012).
41. Hukelmann, J. L. et al. The cytotoxic T cell proteome and its shaping by the kinase mTOR. Nat Immunol 17, 104-112, doi:10.1038/ni.3314 (2016).
42. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13, 2513-2526, doi:10.1074/mcp.M113.031591 (2014).
43. Choi, Y. S. et al. Nuclear IL-33 is a transcriptional regulator of NF-kappaB p65 and induces endothelial cell activation. Biochem Biophys Res Commun 421, 305-311 (2012).
44. Baekkevold, E. S. et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163, 69-79 (2003).
45. Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107, 18581-18586 (2010).
46. Aoki, S. et al. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells. Mol Cell Biochem 335, 75-81 (2010).
47. Montanari, E. et al. Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells. Thromb Haemost 116, doi:10.1160/TH15-12-0917 (2016).
48. Stojkovic, S. et al. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep 6, 25171, doi:10.1038/srep25171 (2016).
49. Talabot-Ayer, D. et al. Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice. J Immunol 194, 750-760, doi:10.4049/jimmunol.1402057 (2015).
50. Vizcaino, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44, D447-D456, doi:10.1093/nar/gkv1145 (2016).